Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0N2AA
|
||||
| Former ID |
DNC000109
|
||||
| Drug Name |
8-aza-DADMe-ImmH
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [535759] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C11H16N5O3+
|
||||
| Canonical SMILES |
C1C(C(C[NH+]1CC2=C3C(=NN2)C(=O)N=CN3)O)CO
|
||||
| InChI |
1S/C11H15N5O3/c17-4-6-1-16(3-8(6)18)2-7-9-10(15-14-7)11(19)13-5-12-9/h5-6,8,17-18H,1-4H2,(H,14,15)(H,12,13,19)/p+1
|
||||
| InChIKey |
SLIJUTHLNPWRDL-UHFFFAOYSA-O
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Purine nucleoside phosphorylase | Target Info | Inhibitor | [535759] | |
| BioCyc Pathway | Arsenate detoxification I (glutaredoxin) | ||||
| Purine nucleotides degradation | |||||
| Urate biosynthesis/inosine 5'-phosphate degradation | |||||
| Purine deoxyribonucleosides degradation | |||||
| Purine ribonucleosides degradation to ribose-1-phosphate | |||||
| Guanosine nucleotides degradation | |||||
| Adenosine nucleotides degradation | |||||
| Superpathway of purine nucleotide salvage | |||||
| Adenine and adenosine salvage III | |||||
| Guanine and guanosine salvage | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| PathWhiz Pathway | Purine Metabolism | ||||
| Nicotinate and Nicotinamide Metabolism | |||||
| Reactome | Purine salvage | ||||
| Purine catabolism | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.